5 Fluorouracil Ebewe belongs to the group of anticancer drugs and acts on the immune system.
The drug has the main ingredient Fluorouracil 50mg/ml, which is used for the palliative treatment of some cancers such as: Colon, rectal, stomach and breast cancer
How to use:
Administration 5 Fluorouracil Ebewe is prepared as an infusion solution that should be administered by intravenous or intravenous injection.
The drug solution will irritate when in contact with the skin and mucous membranes. Therefore, only specially trained personnel should open ampoules.
Caution & Warnings:
5-Fluorouracil Ebewe should only be used under the close supervision of the oncologist and the patient needs to be hospitalized for at least the first course of treatment.
During treatment, it is necessary to monitor hematology every 2-3 days. In maintenance treatment, it is necessary to check the blood count, liver function, kidney function, oral cavity regularly before taking the drug.
Side Effects:
Blood: Myelosuppression with leukopenia and neutrophils
immunosuppression and anemia.
Gastrointestinal tract: Mucositis, stomatitis, anorexia, pharyngitis, esophagitis, enteritis, gastrointestinal ulceration, gastrointestinal bleeding, malabsorption of food, nausea, vomiting and diarrhea.
5 Fluorouracil Ebewe belongs to the group of anticancer drugs and acts on the immune system.
The drug has the main ingredient Fluorouracil 50mg/ml, which is used for the palliative treatment of some cancers such as: Colon, rectal, stomach and breast cancer
How to use:
Administration 5 Fluorouracil Ebewe is prepared as an infusion solution that should be administered by intravenous or intravenous injection.
The drug solution will irritate when in contact with the skin and mucous membranes. Therefore, only specially trained personnel should open ampoules.
Caution & Warnings:
5-Fluorouracil Ebewe should only be used under the close supervision of the oncologist and the patient needs to be hospitalized for at least the first course of treatment.
During treatment, it is necessary to monitor hematology every 2-3 days. In maintenance treatment, it is necessary to check the blood count, liver function, kidney function, oral cavity regularly before taking the drug.
Side Effects:
Blood: Myelosuppression with leukopenia and neutrophils
immunosuppression and anemia.
Gastrointestinal tract: Mucositis, stomatitis, anorexia, pharyngitis, esophagitis, enteritis, gastrointestinal ulceration, gastrointestinal bleeding, malabsorption of food, nausea, vomiting and diarrhea.